DISPARITIES IN IMMUNOTHERAPY ACCESS FOR STAGE IV PANCREATIC ADENOCARCINOMA

被引：0
|
作者：
Khalid, Abdullah
Shah, Manav J.
Ahmed, Hanaa
Amini, Neda
Demyan, Lyudmyla
Pasha, Shamsher
Newman, Elliot
Weiss, Matthew
King, Daniel A.
Melis, Marcovalerio
机构：
来源：
GASTROENTEROLOGY | 2024年 / 166卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1483
引用
收藏
页码：S1910 / S1911
页数：2
相关论文
共 50 条
  • [1] Racial Disparities in the Outcomes of Patients With Stage IV Pancreatic Adenocarcinoma Are Mediated by Chemotherapy Utilization
    Atkins, Jordan J.
    Fiala, Mark A.
    Wang-Gillam, Andrea
    Wildes, Tanya M.
    PANCREAS, 2016, 45 (07) : E33 - E34
  • [2] Racial Disparities in the Outcomes of Patients With Stage IV Pancreatic Adenocarcinoma Are Mediated by Chemotherapy Utilization Reply
    Van Buren, George, II
    PANCREAS, 2016, 45 (07) : E34 - E35
  • [3] Racial Ethnic Disparities in Access to Neoadjuvant Therapy for Pancreatic Adenocarcinoma
    Kangas-Dick, A. W.
    Greenbaum, A. A.
    Gazivoda, V. P.
    Hilden, P. D.
    Gall, V. A.
    Sesti, J.
    Paul, S.
    August, D. A.
    Kennedy, T. J.
    Grandhi, M. S.
    Alexander, H. R.
    Maggi, J. C.
    Langan, R. C.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 1) : S91 - S91
  • [4] CURRENT STATUS OF IMMUNOTHERAPY IN STAGE-IV RENAL ADENOCARCINOMA
    KLOTZ, SD
    SWEENEY, MJ
    JOURNAL OF THE FLORIDA MEDICAL ASSOCIATION, 1983, 70 (01): : 39 - 42
  • [5] COMPOSITE QUALITY SCORE AMONG PATIENTS WITH STAGE IV PANCREATIC ADENOCARCINOMA: RACIAL / ETHNIC DISPARITIES AND IMPACT ON OUTCOMES
    Tsilimigras, Diamantis
    Woldesenbet, Selamawit
    Khan, Muhammad Muntazir M.
    Pawlik, Timothy M.
    GASTROENTEROLOGY, 2024, 166 (05) : S1904 - S1904
  • [6] Disparities in use of immunotherapy for stage III and IV melanoma patients.
    White, Richard L.
    Trufan, Sally Jeanne
    Gower, Nicole Lee
    Neelands, Brittany
    Amin, Asim
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [7] Decompositions of the Contribution of Treatment Disparities to Survival Disparities in Stage I–II Pancreatic Adenocarcinoma
    Douglas S. Swords
    Courtney L. Scaife
    Annals of Surgical Oncology, 2021, 28 : 3157 - 3168
  • [8] Impact of immunotherapy use in patients with stage IV pancreatic carcinoma
    Guddati, Achuta K.
    Komiya, Takefumi
    Patel, Sunny J.
    Sharma, Neil
    Powell, Emily
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2020, 11 (04) : 654 - 662
  • [9] Decompositions of the Contribution of Treatment Disparities to Survival Disparities in Stage I-II Pancreatic Adenocarcinoma
    Swords, Douglas S.
    Scaife, Courtney L.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (06) : 3157 - 3168
  • [10] Referral patterns and predictors of survival for stage IV pancreatic ductal adenocarcinoma
    Suo, A. E.
    Tang, P. A.
    Tilley, D.
    Cheung, W. Y.
    Lee-Ying, R.
    ANNALS OF ONCOLOGY, 2018, 29
12345